Skip to content

Effect of local spraying magnesium sulfate on sore throat after gynecological laparoscopic surgery

Effect of local spraying magnesium sulfate on sore throat after gynecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087240
Enrollment
Unknown
Registered
2024-07-23
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative sore throat

Interventions

Spray saline group:Before intubation, the laryngeal mucosa near the glottis and the posterior pharyngeal wall were sprayed with equal-volume saline with a laryngeal anesthetic tube under visual laryng
Spray magnesium sulfate group:Before intubation, magnesium sulfate (15mg/kg) was sprayed on the throat mucosa near the glottis and the posterior pharyngeal wall with a laryngeal tube under visual lary

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing gynecological surgery; 2. ASA grade I - II; 3. Aged 18 to 65 years old; 4. BMI 18-30kg/?;

Exclusion criteria

Exclusion criteria: 1. Oral ulcer, sore throat, throat mucosa injury, pharyngitis before operation; 2. Preoperative nausea, vomiting, cough, dysphagia; 3. History of laryngeal surgery; 4. Mallampati graded 2 or above; 5. Preoperative hypermagnesia or allergy to magnesium; 6. Recent respiratory infectious diseases; 7. Preoperative hypoalbuminemia; 8. Smoking history; 9. Preoperative nasogastric tube placement; 10. Decompensated heart disease (heart failure, myocardial infarction, severe arrhythmia); 11. Severe respiratory diseases (severe obstructive or restrictive lung disease, respiratory failure); 12. Severe liver dysfunction (serum total bilirubin >= 2mg/dl); 13. Severe renal dysfunction (glomerular filtration rate < 60ml/ (min·1.73m2); 14. Patients receiving chronic treatment with calcium channel blockers or magnesium. 15. Contraindications of magnesium sulfate: acute intestinal bleeding, acute abdomen, pregnancy, lactation.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative sore throat;

Secondary

MeasureTime frame
NRS score immediately after extubation, 2h, 6h, 12h, 24h, 48h postoperative sore throat;Incidence and grade of cough during extubation;Incidence of postoperative nausea and vomiting;Incidence of postoperative dysphagia;Incidence of hoarseness immediately after extubation, 2h, 6h, 12h, 24h, 48h after surgery;Preoperative albumin levels;Serum magnesium ion concentration before operation;Postoperative serum magnesium ion concentration;Intraoperative remifentanil consumption;Intraoperative atropine dosage;Intraoperative infusion volume;Hemodynamic indexes 5min after intubation and every 30min during operation;Intraoperative urine volume;Intraoperative airway pressure;Tracheal catheter cuff pressure;The 15-item Quality of Recovery Score Scale (QoR-15) score 48h after surgery;Remedial analgesics within 24 hours after surgery;

Countries

China

Contacts

Public ContactGuanglei Wang

Affiliated Hospital of Xuzhou Medical University

13852087156@163.com+86 138 5208 7156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026